vs
NL INDUSTRIES INC(NL)与RECURSION PHARMACEUTICALS, INC.(RXRX)财务数据对比。点击上方公司名可切换其他公司
NL INDUSTRIES INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.1倍($37.7M vs $35.5M),NL INDUSTRIES INC净利率更高(-82.2% vs -304.2%,领先222.1%),RECURSION PHARMACEUTICALS, INC.同比增速更快(681.7% vs -1.9%),NL INDUSTRIES INC自由现金流更多($-4.7M vs $-47.3M),过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高(60.5% vs -0.4%)
NL工业公司前身为国民铅业公司,是一家铅冶炼企业,目前总部位于美国得克萨斯州休斯顿。该企业历史底蕴深厚,早在1896年5月26日道琼斯工业平均指数创立之初,NL工业就是最初纳入指数的12只成分股之一。
Recursion Pharmaceuticals是一家临床阶段生物技术企业,依托人工智能技术和高通量生物实验体系,开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法,核心市场覆盖北美,与全球多家生物制药企业合作推进在研管线落地。
NL vs RXRX — 直观对比
营收规模更大
NL
是对方的1.1倍
$35.5M
营收增速更快
RXRX
高出683.6%
-1.9%
净利率更高
NL
高出222.1%
-304.2%
自由现金流更多
NL
多$42.6M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-0.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $37.7M | $35.5M |
| 净利润 | $-31.0M | $-108.1M |
| 毛利率 | 32.1% | 59.8% |
| 营业利润率 | 7.6% | -304.8% |
| 净利率 | -82.2% | -304.2% |
| 营收同比 | -1.9% | 681.7% |
| 净利润同比 | -287.2% | 39.6% |
| 每股收益(稀释后) | $-0.63 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
NL
RXRX
| Q4 25 | $37.7M | $35.5M | ||
| Q3 25 | $40.0M | $5.2M | ||
| Q2 25 | $40.4M | $19.2M | ||
| Q1 25 | $40.3M | $14.7M | ||
| Q4 24 | $38.4M | $4.5M | ||
| Q3 24 | $33.7M | $26.1M | ||
| Q2 24 | $35.9M | $14.4M | ||
| Q1 24 | $38.0M | $13.8M |
净利润
NL
RXRX
| Q4 25 | $-31.0M | $-108.1M | ||
| Q3 25 | $-7.9M | $-162.3M | ||
| Q2 25 | $355.0K | $-171.9M | ||
| Q1 25 | $667.0K | $-202.5M | ||
| Q4 24 | $16.5M | $-178.9M | ||
| Q3 24 | $36.0M | $-95.8M | ||
| Q2 24 | $7.8M | $-97.5M | ||
| Q1 24 | $6.8M | $-91.4M |
毛利率
NL
RXRX
| Q4 25 | 32.1% | 59.8% | ||
| Q3 25 | 27.6% | -183.8% | ||
| Q2 25 | 31.9% | -4.9% | ||
| Q1 25 | 30.2% | -48.0% | ||
| Q4 24 | 28.8% | -181.4% | ||
| Q3 24 | 28.1% | 53.7% | ||
| Q2 24 | 31.1% | 36.2% | ||
| Q1 24 | 25.5% | 19.1% |
营业利润率
NL
RXRX
| Q4 25 | 7.6% | -304.8% | ||
| Q3 25 | 4.6% | -3327.6% | ||
| Q2 25 | 6.9% | -916.8% | ||
| Q1 25 | 7.8% | -1297.9% | ||
| Q4 24 | 87.7% | -4042.4% | ||
| Q3 24 | 6.0% | -377.1% | ||
| Q2 24 | 2.2% | -697.4% | ||
| Q1 24 | 3.6% | -698.4% |
净利率
NL
RXRX
| Q4 25 | -82.2% | -304.2% | ||
| Q3 25 | -19.7% | -3135.3% | ||
| Q2 25 | 0.9% | -894.2% | ||
| Q1 25 | 1.7% | -1373.3% | ||
| Q4 24 | 43.1% | -3935.5% | ||
| Q3 24 | 107.0% | -367.5% | ||
| Q2 24 | 21.8% | -676.6% | ||
| Q1 24 | 18.0% | -662.4% |
每股收益(稀释后)
NL
RXRX
| Q4 25 | $-0.63 | $-0.17 | ||
| Q3 25 | $-0.16 | $-0.36 | ||
| Q2 25 | $0.01 | $-0.41 | ||
| Q1 25 | $0.01 | $-0.50 | ||
| Q4 24 | $0.34 | $-0.56 | ||
| Q3 24 | $0.74 | $-0.34 | ||
| Q2 24 | $0.16 | $-0.40 | ||
| Q1 24 | $0.14 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $358.8M | $1.1B |
| 总资产 | $464.2M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
NL
RXRX
| Q4 25 | $110.6M | $743.3M | ||
| Q3 25 | $101.9M | $659.8M | ||
| Q2 25 | $111.5M | $525.1M | ||
| Q1 25 | $110.0M | $500.5M | ||
| Q4 24 | $163.2M | $594.4M | ||
| Q3 24 | $146.0M | $427.6M | ||
| Q2 24 | $179.4M | $474.3M | ||
| Q1 24 | $167.9M | $296.3M |
总债务
NL
RXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益
NL
RXRX
| Q4 25 | $358.8M | $1.1B | ||
| Q3 25 | $375.4M | $1.0B | ||
| Q2 25 | $397.6M | $919.1M | ||
| Q1 25 | $397.6M | $933.9M | ||
| Q4 24 | $396.9M | $1.0B | ||
| Q3 24 | $386.0M | $524.6M | ||
| Q2 24 | $373.1M | $584.4M | ||
| Q1 24 | $368.1M | $401.2M |
总资产
NL
RXRX
| Q4 25 | $464.2M | $1.5B | ||
| Q3 25 | $500.2M | $1.4B | ||
| Q2 25 | $523.7M | $1.3B | ||
| Q1 25 | $520.0M | $1.3B | ||
| Q4 24 | $578.3M | $1.4B | ||
| Q3 24 | $585.6M | $726.5M | ||
| Q2 24 | $580.0M | $775.9M | ||
| Q1 24 | $568.8M | $557.8M |
负债/权益比
NL
RXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-4.2M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-4.7M | $-47.3M |
| 自由现金流率自由现金流/营收 | -12.6% | -133.1% |
| 资本支出强度资本支出/营收 | 1.6% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-40.1M | $-378.3M |
8季度趋势,按日历期对齐
经营现金流
NL
RXRX
| Q4 25 | $-4.2M | $-46.1M | ||
| Q3 25 | $7.9M | $-117.4M | ||
| Q2 25 | $7.3M | $-76.4M | ||
| Q1 25 | $-47.5M | $-132.0M | ||
| Q4 24 | $9.0M | $-115.4M | ||
| Q3 24 | $-5.7M | $-59.2M | ||
| Q2 24 | $15.5M | $-82.2M | ||
| Q1 24 | $6.7M | $-102.3M |
自由现金流
NL
RXRX
| Q4 25 | $-4.7M | $-47.3M | ||
| Q3 25 | $7.0M | $-117.6M | ||
| Q2 25 | $5.9M | $-79.6M | ||
| Q1 25 | $-48.3M | $-133.8M | ||
| Q4 24 | $8.7M | $-116.7M | ||
| Q3 24 | $-6.1M | $-63.8M | ||
| Q2 24 | $15.1M | $-83.4M | ||
| Q1 24 | $6.4M | $-109.0M |
自由现金流率
NL
RXRX
| Q4 25 | -12.6% | -133.1% | ||
| Q3 25 | 17.4% | -2272.5% | ||
| Q2 25 | 14.7% | -413.9% | ||
| Q1 25 | -119.9% | -907.4% | ||
| Q4 24 | 22.8% | -2567.7% | ||
| Q3 24 | -18.3% | -244.6% | ||
| Q2 24 | 42.1% | -578.5% | ||
| Q1 24 | 17.0% | -789.9% |
资本支出强度
NL
RXRX
| Q4 25 | 1.6% | 3.5% | ||
| Q3 25 | 2.5% | 4.7% | ||
| Q2 25 | 3.3% | 16.4% | ||
| Q1 25 | 2.0% | 12.4% | ||
| Q4 24 | 0.6% | 28.6% | ||
| Q3 24 | 1.4% | 17.5% | ||
| Q2 24 | 1.2% | 8.2% | ||
| Q1 24 | 0.8% | 48.2% |
现金转化率
NL
RXRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 20.53× | — | ||
| Q1 25 | -71.18× | — | ||
| Q4 24 | 0.54× | — | ||
| Q3 24 | -0.16× | — | ||
| Q2 24 | 1.98× | — | ||
| Q1 24 | 0.99× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NL
| Security Products | $29.5M | 78% |
| Marine Components | $8.2M | 22% |
RXRX
暂无分部数据